Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06396247 · ClinicalTrials.gov registry record · Phase 2
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
A Phase 2 study of Mobility Limitation, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 360
- Enrollment target
- 2
- Study locations
NCT06396247: Recruiting Phase 2 study of Mobility Limitation, sponsored by Milton S. Hershey Medical Center.
NCT06396247 is a Phase 2 study of Mobility Limitation that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 360 participants, above the 243-participant average among 28 other Mobility Limitation trials with a reported enrollment target (48% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06396247, a Phase 2 study of Mobility Limitation, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 360 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the training on measures of lower extremity performance and walking ability.
Primary Outcome
The SPPB assesses balance, gait speed, and lower extremity strength.
Conditions Studied
Interventions
- BEHAVIORAL Functional Activity Strength Training
Study Locations (2)
Pennsylvania
- Penn State College of Medicine - Hershey
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2025-04-09 |
| Est. Completion | 2028-09 |
| Phase | Phase 2 |
What NCT06396247 shows while recruiting
NCT06396247 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, above the 243-participant average among 28 other Mobility Limitation trials with a reported enrollment target (48% higher).
The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which Functional Activity Strength Training is the first listed.
NCT06396247 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06396247 about?
NCT06396247 is a clinical study titled "Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance". In this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the training on measures of lower extremity performance and walking ability.
What is the current status of trial NCT06396247?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 360 participants. The study started on 2025-04-09. Estimated completion is 2028-09.
What conditions does trial NCT06396247 study?
This clinical trial studies the following conditions: Mobility Limitation.
What interventions are being tested in trial NCT06396247?
The interventions under investigation include: Functional Activity Strength Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06396247?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06396247 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06396247's enrollment target sits among peer trials
360 5th of 28 higher than 24 of 28 other Mobility Limitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Living Independence Through Functional Training
RECRUITING · Phase 1
-
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI